BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15563531)

  • 1. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
    Weinberg EO; Scherrer-Crosbie M; Picard MH; Nasseri BA; MacGillivray C; Gannon J; Lian Q; Bloch KD; Lee RT
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1802-9. PubMed ID: 15563531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.
    Bulhak A; Roy J; Hedin U; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3158-63. PubMed ID: 17322412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
    Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
    Wu N; Li W; Lv Y; Shu W; Jia D
    Pharmazie; 2014 Sep; 69(9):704-8. PubMed ID: 25272944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
    Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.
    Jones SP; Gibson MF; Rimmer DM; Gibson TM; Sharp BR; Lefer DJ
    J Am Coll Cardiol; 2002 Sep; 40(6):1172-8. PubMed ID: 12354446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
    D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.
    Naito Y; Katada K; Takagi T; Tsuboi H; Kuroda M; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    World J Gastroenterol; 2006 Apr; 12(13):2024-30. PubMed ID: 16610051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J; Wang K; Fan L; Jiang Y; Shi Z
    Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
    Ke D; Fang J; Fan L; Chen Z; Chen L
    Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
    Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
    Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase.
    Jones SP; Girod WG; Palazzo AJ; Granger DN; Grisham MB; Jourd'Heuil D; Huang PL; Lefer DJ
    Am J Physiol; 1999 May; 276(5):H1567-73. PubMed ID: 10330240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
    Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
    Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
    CAI W; FANG J; CHEN ZY; LIN YL; WU LM; CHEN LL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):814-8. PubMed ID: 21092651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
    Ikeda Y; Young LH; Lefer AM
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):649-56. PubMed ID: 12658068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M
    Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of infarct size by short-term pretreatment with atorvastatin.
    Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.